Ausgabe 5/2022
Inhalt (6 Artikel)
ANKRD26-Related Thrombocytopenia and Predisposition to Myeloid Neoplasms
Mia J. Sullivan, Elizabeth L. Palmer, Juliana Perez Botero
Germline and Somatic Defects in DDX41 and its Impact on Myeloid Neoplasms
Talha Badar, Timothy Chlon
Management of Chronic Myeloid Leukemia in Children and Young Adults
Maegan Ford, Michael Mauro, Catherine Aftandilian, Kathleen M. Sakamoto, Nobuko Hijiya
Towards a Personalized Definition of Prognosis in Philadelphia-Negative Myeloproliferative Neoplasms
Barbara Mora, Francesco Passamonti
Novel Therapies in Myelofibrosis: Beyond JAK Inhibitors
Julian A. Waksal, John Mascarenhas
Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia
Ivan Krecak, Marko Lucijanic, Srdan Verstovsek